
Profitability, historical returns, and peer comparisons.
According to TerrAscend Corp.’s latest financial reports and current stock price. The company's current ROE is -25.94%. This represents a change of 273.34% compared to the average of -6.95% of the last 4 quarters.
The mean historical ROE of TerrAscend Corp. over the last ten years is -1375.50%. The current -25.94% ROE has changed -98.11% with respect to the historical average. Over the past ten years (40 quarters), TRSSF's ROE was at its highest in in the December 2020 quarter at 712.71%. The ROE was at its lowest in in the December 2019 quarter at -254.20%.
Average
-1375.50%
Median
-43.50%
Minimum
-13068.49%
Maximum
1.39%
Discovering the peaks and valleys of TerrAscend Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.94%
Maximum Annual ROE = 1.39%
Minimum Annual Increase = -7316.11%
Minimum Annual ROE = -13068.49%
| Year | ROE | Change |
|---|---|---|
| 2025 | -90.17% | 98.87% |
| 2024 | -45.34% | 20.69% |
| 2023 | -37.57% | -62.58% |
| 2022 | -100.41% | -7316.11% |
| 2021 | 1.39% | -100.01% |
| 2020 | -13068.49% | 3.94% |
| 2019 | -323.62% | 729.64% |
| 2018 | -39.01% | 286.15% |
| 2017 | -10.10% | -75.76% |
| 2016 | -41.67% | -131.11% |
The current ROE of TerrAscend Corp. (TRSSF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-57.69%
5-year avg
-54.42%
10-year avg
-1375.50%
TerrAscend Corp.’s ROE is greater than Columbia Care Inc. (-106.90%), less than Adcock Ingram Holdings Limited (15.27%), greater than Inventiva S.A. (-1625.48%), less than Ceryvyn Therapeutics Ltd (0%), greater than Kindstar Globalgene Technology, Inc. (-1.56%), less than PT Tempo Scan Pacific Tbk (13.73%), greater than Claritas Pharmaceuticals, Inc. (-436.27%), less than China Shineway Pharmaceutical Group Limited (9.81%), less than PeakBirch Commerce Inc. (796.30%), less than Xvivo Perfusion AB (publ) (5.89%),
| Company | ROE | Market cap |
|---|---|---|
| -106.90% | $521.35M | |
| 15.27% | $624.32M | |
| -1625.48% | $760.35M | |
| 0% | $14.64M | |
| -1.56% | $675.13M | |
| 13.73% | $463.12M | |
| -436.27% | $3.66K | |
| 9.81% | $758.42M | |
| 796.30% | $544.73M | |
| 5.89% | $173.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TerrAscend Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TerrAscend Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is TerrAscend Corp.'s ROE?
How is the ROE calculated for TerrAscend Corp. (TRSSF)?
What is the highest ROE for TerrAscend Corp. (TRSSF)?
What is the 3-year average ROE for TerrAscend Corp. (TRSSF)?
What is the 5-year average ROE for TerrAscend Corp. (TRSSF)?
How does the current ROE for TerrAscend Corp. (TRSSF) compare to its historical average?